Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of patients with major atherosclerotic cardiovascular disease events in the United States.

Baum, Seth J; Rane, Pallavi B; Nunna, Sasikiran; Habib, Mohdhar; Philip, Kiran; Sun, Kainan; Wang, Xin; Wade, Rolin L

Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of patients with major atherosclerotic cardiovascular disease events in the United States.

Baum, Seth J; Rane, Pallavi B; Nunna, Sasikiran; Habib, Mohdhar; Philip, Kiran; Sun, Kainan; Wang, Xin; Wade, Rolin L.

Afiliação

Baum SJ; Department of Integrated Medical Sciences, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL USA.
Rane PB; Amgen Inc., Thousand Oaks, CA USA.
Nunna S; IQVIA, Plymouth Meeting, PA USA.
Habib M; Amgen Inc., Thousand Oaks, CA USA.
Philip K; Amgen Inc., Thousand Oaks, CA USA.
Sun K; IQVIA, Plymouth Meeting, PA USA.
Wang X; IQVIA, Plymouth Meeting, PA USA.
Wade RL; IQVIA, Plymouth Meeting, PA USA.

Am J Prev Cardiol ; 6: 100177, 2021 Jun.

Article em En | MEDLINE | ID: mdl-34327500

Palavras-chave

Atherosclerotic cardiovascular disease; LDL-C; Lipid-lowering therapy; Very high-risk

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Prev Cardiol Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google